Showing posts with label trials. Show all posts
Showing posts with label trials. Show all posts

Tuesday, March 12, 2013

PatientsLikeMe Unveils New Tool to Match Patients With Clinical Trials Worldwide


The U.S.-based patient network and real-time research platform PatientsLikeMe unveils its global clinical trials tool today at Europe's Healthcare Innovation Expo 2013, hosted by the National Health Service (NHS). The free tool, unveiled today by Research Director Paul Wicks Ph.D., draws on open data to match patients from around the globe with clinical trials based on their condition and location. The U.S. prototype was launched last year and has already helped thousands of patients find suitable clinical trials. The tool is available at http://www.patientslikeme.com/clinical_trials.
"Open data helps us accelerate the pace of research, and it's crucial we do everything possible to match patients to trials that might advance treatment and help them live better with their condition," says Wicks, a newly named TED Fellow and UK scientist. "We're excited to be at this year's Expo to learn what British and European healthcare innovation has in store for the NHS."
Last week, PatientsLikeMe Co-founder and Chairman Jamie Heywood spoke about innovative solutions to healthcare at the 2013 Nuffield Trust Health Policy Summit in London. Nuffield Trust is an independent source of evidence-based research and policy analysis for improving health care in the UK. Heywood returns to London tomorrow to speak on the Expo's Masterclass Stage about the importance of measurement in building a learning health system.
In his Nuffield speech, Heywood called for a "revolution in measurement," or what he calls "measurement-based medicine." He adds, "We should measure the severity of each condition and its impact on the patient. The measurement should support the patient in life choices, clinicians in care choices and researchers in learning what's effective. And every patient should be measured as part of the care process to the degree appropriate for the severity of their condition, so that their experience can be used to guide the next patient."
About PatientsLikeMe
PatientsLikeMe is a patient network that improves lives and a real-time research platform that advances medicine. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that help researchers, pharmaceutical companies, regulators, providers and nonprofits develop more effective products, services and care. PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 30 peer-reviewed research studies. Visit us at www.patientslikeme.com or follow us on our blog, on Twitter or via Facebook.

CONTACT:

Lori Scanlon
Office: +1 617.229.6643
Mobile: +1 774.217.1330
lscanlon@patientslikeme.com

Source:
PatientsLikeMe Unveils New Tool to Match Patients With Clinical Trials Worldwide



See also:

Art Kallow Selected as a Thought Leader for Upcoming Thomson Reuters Family Law Book
Attorney Art Kallow of the internationally respected firm, The Law Offices of Jeffery M. Leving, Ltd. has been invited to write a thought leadership essay for the new Aspatore Inside the Minds book,...

Report: Only 50% of UK Top 100 Online Retailers Websites Have Optimized for Mobile vs 100% of US
Skava, the leading provider of multi-touch point retail technology, today announced that as part of a recent study, only half of the top 100 UK retailers have optimized their websites for mobile...

MusclePharm to Present at the Peak to Peak Institutional Conference
MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company focused on active lifestyles, is proud to announce the Company will be presenting at the 2013 Peak to Peak Institutional...

Sunday, January 27, 2013

Easterm Clinical Trials Moscow Russia Contract Research Organization Joins ACTO

On December 13, 2012 Eastern Clinical Trials (ECT), a contract research organization (CRO) with operations in Russia, Central and Eastern Europe, has been accepted into the Association of Clinical Trials Organizations (ACTO)."We are honored to become a part of ACTO, an organization consisting of the most reputable Pharmaceutical Companies and CROs operating in Russia", said Dr. Svetlana Vodolazhskaya, ECT's Managing Director. "We feel that it is important to support ACTO's ongoing interactions with the governmental agencies responsible for local clinical trial regulations and laws".

About Eastern Clinical Trials (ECT http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

About Association of Clinical Trial Organizations (ACTO http://www.acto-russia.org)
ACTO is a non-commercial organization of companies, legal entities and the clinical research community engaged in clinical trials in Russia.

Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana(dot)vodolazhskaya(at)easterntrials(dot)com

News source: PRWeb

Source:
Easterm Clinical Trials Moscow Russia Contract Research Organization Joins ACTO



See also:

Seasoned Business Expert Joins ARS as General Manager of San Diego Heating and Air Conditioning Business
ARS, a leading brand of American Residential Services and one of its premier heating and air conditioning service companies nationwide, is pleased to announce the addition of Art Hagopian as General...

Xocai Healthy Chocolate, a Delicious Healthy Chocolate Alternative, Announces Highest Earning Distributors Named to Top Producer's List By MXI Corp
Marketing Xocolate International Corporation (MXI-Corp) announces its top 10 producers, which is comprised of distributors who have achieved Executive level or higher with the highest earnings.This...

BLOOMBERG: Shadow Inventory Remains High in 2013
Bloomberg TV reports that the total shadow inventory could be as high as 3.67 million homes.Shadow inventory is a term used to describe homes that are purposely kept off the market, the motivation...